Dehydroepiandrosterone Status in Postmenopausal Women is Determined by the Gene for the Vitamin D Receptor

Abstract

Data documenting the indirect interaction of vitamin D and bone metabolism via hormonal systems are rare. The authors analysed the predictive role of the vitamin D receptor (VDR) gene for circulating sex steroids and their precursors in postmenopausal women. Using the PCR technique, the polymorphic FokI, ApaI, TaqI and BsmI sites of the VDR gene were determined in relation to serum dehydroepiandrosterone sulphate (DHEAS), androstenedione (AD), testosterone, and estradiol levels. After adjustment to body mass and years since menopause, circulating DHEAS was higher in the Ff genotype than in ff (p < 0.001) and FF genotypes (p < 0.05, ANCOVA followed by least significant difference multiple comparison tests). The Ff genotype also contributed to the highest BMD at the hip (p < 0.01 as compared to ff genotype) and at the spine (p < 0.05). No significant associations were found between ApaI, TaqI and BsmI polymorphisms and serum DHEAS or between FokI, ApaI, TaqI or BsmI and serum androstenedione, testosterone or estradiol. The study shows that the VDR gene predicts synthesis and/or metabolism of sexual steroid preursor DHEA in parallel with bone mineral density (BMD). The results indicate that DHEA production and bone mass share a common genetic control through VDR.

Key words

Genetics - Bone Mineral Density - Sex-Steroids - Androstenedione

References

• 1 Morrison N A, Yeoman R, Kelly P J, Eisman J A. Contribution of trans-activating factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin.  Proc Natl Acad Sci U.S.A.. 1992;  89 6665-6669
• 2 Harris S, Eccleshall T R, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black white women.  J Bone Miner Res. 1997;  12 1043-1048
• 3 Gennari L, Becherini L, Mansani R, Masi L, Falchetti A, Morelli A, Colli E, Gonnelli S, Cepollaro C, Brandi M L. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fracture in postmenopausal Italian women.  J Bone Miner Res. 1999;  14 1379-1386
• 4 Deng H W, Li J, Li J L, Johnson M, Gong G, Davis K M, Recker R R. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes.  Hum Genet. 1998;  103 576-585
• 5 Lea C K, Moxham V, Reed M J, Flanagan A M. Androstenedione treatment reduces loss of cancelous bone volume in ovariectomized rats in a dose-responsive manner and the effect is not mediated by oestrogen.  J Endocrinology. 1998;  156 331-339
• 6 Martel C, Sourla A, Pelletier G, Labrie C, Fournier M, Picard S, Li S, Stojanovic M, Labrie F. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.  J Endocrinology. 1998;  157 433-442
• 7 Žofková I, Bahbouh R, Hill M. The pathophysiological implications of circulating androgens on bone mineral density in a normal female population.  Steroids. 2000;  65 857-861
• 8 Huang J, Ushiyama T, Inoue K, Mori K, Hukuda S. Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis.  Clin Exp Rheumatol. 1999;  17 721-724
• 9 Durocher F, Morissette J, Labrie Y, Labrie F, Simard J. Mapping of the HSD17B2 gene encoding type II 17β-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2.  Genomics. 1995;  25 724-726
• 10 Putz Z, Hampl R, Vaňuga A, Velemínsk¿ J, Stárka L. A selective radioimmunoassay of androstenedione in plasma and saliva.  J Clin Chem Clin Biochem. 1982;  20 761-764
• 11 Gross C, Eccleshall T R, Malloy P J, Villa M L, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.  J Bone Miner Res. 1996;  11 1850-1855
• 12 Riggs B L, Nguyen T V, Melton L J, Morrison N A, O’Fallon W M, Kelly P J, Egan K S, Sambrook P N, Muhs J M, Eisman J A. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women.  J Bone Miner Res. 1995;  10 991-996
• 13 Morrison N A, Qi J C, Tokita A, Kelly P J, Crofts L, Nguyen T V, Sambrook P N, Eisman J A. Prediction of bone density by vitamin D receptor alleles.  Nature. 1994;  367 284-287
• 14 Jorgensen H L, Scholler J, Sand J C, Bjuring M, Hassager C, Christiansen C. Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: cross-sectional and longitudinal population study.  Br Med J. 1996;  313 586-590
• 15 Vandevyver C, Wylin T, Cassiman J J, Raus J, Geusens P. Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women.  J Bone Miner Res. 1997;  12 241-247
• 16 Simmons J D, Mullighan C, Welsh K I, Jewell D P. Vitamin D receptor gene polymorphism: Association with Crohn’s disease susceptibility.  Gut. 2000;  47 211-214
• 17 Halmos B, Szalay F, Cserniczky T, Nemesanszky E, Lakatos P, Barlage S, Schmitz G, Romicz L, Csaszar A. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population.  Dig Dis Sci. 2000;  45 1091-1095
• 18 Loughlin J, Sinsheimer J S, Mustafa Z, Carr A J, Clipsham K, Bloomfield V A, Chitnavis J, Bailey A, Sykes B, Chapman K. Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis.  J Rheumatol. 2000;  27 779-784
• 19 Aterini S, Pacini S, Amato M, Ruggiero M. Vitamin D receptor gene polymorphism and diabetes mellitus prevalence in hemodialysis patients.  Nephron. 2000;  84 186
• 20 Stumpf W E, Sar M, O’Brien L P. Vitamin D sites of action in the pituitary studies by combined autoradiography-immunohistochemistry.  Histochemistry. 1987;  88 11-16
• 21 Žofková I, Bednář J. Effect of 1,25(OH)₂ vitamin D₃ (calcitriol) on TRH-induced thyrotropin secretion in man.  Exp Clin Endocrinol. 1988;  91 7-12
• 22 Žofková I, Nedvídková J. Effect of 1,25-dihydroxyvitamin D₃ (calcitriol) on prolactin secretion at rest and TRH-stimulated secretion in humans.  Exp Clin Endocrinol. 1988;  91 207-211